COST-EFFECTIVENESS ANALYSIS OF USTEKINUMAB VERSUS ADALIMUMAB, INFLIXIMAB AND VEDOLIZUMAB FOR THE TREATMENT OF PATIENTS WITH MODERATELY TO SEVERE ACTIVE CROHN'S DISEASE FOR TURKEY
VALUE IN HEALTH, vol.21, 2018 (SCI-Expanded, SSCI, Scopus)
- Publication Type: Article / Abstract
- Volume: 21
- Publication Date: 2018
- Doi Number: 10.1016/j.jval.2018.09.863
- Journal Name: VALUE IN HEALTH
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus
- Trakya University Affiliated: Yes